Unless otherwise noted, speakers have nothing to disclose.

Moderators

Jane Yanagawa, MD
Disclosure: ICONA BioDx: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IDEOlogy Health: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Lewis Brisbois Bisgaard and Smith LLP: Subpoena for deposition (Terminated)

Loretta Erhunmwunsee, MD
Disclosure: Astra Zeneca: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated), Speaker (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Gilead Oncology: Speaker (Terminated)

Presentations

1. Oligometastic NSCLC
   Michael Lanuti, MD
   Disclosure: Iovance Biotherapeutics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
    
2. Evaluation of surgical contraindications and disparities in surgical management of non-metastatic lung cancer
   Aria Bassiri, MD
    
3. Impact of Active Smoking on Postoperative Complications After Lung Resection. Results from the French Society for Thoracic and Cardiovascular Surgery (SFCTCV) database
   Francesco Leo
    
4. Association between Interstitial Lung Disease and Outcomes after Pulmonary Resection for Non-Small Cell Lung Cancer – Analysis of the STS General Thoracic Surgery Database
   Andrea L. Axtell, MD, MPH